court ruling on tirzepatide US judge sides with FDA's removal of Lilly's weight loss drug from shortage list Tirzepatide Lawsuit Against the FDA:

According to NICE guidance (NG28) , GLP-1 receptor agonists like Trulicity are usually considered after failure of triple oral therapy and recommended for adults with type 2 diabetes who have inadequate glycaemic control and a body mass index (BMI) of 35 kg/m or higher (with adjustment for ethnicity where appropriate), or for those with a BMI lower than 35 kg/m when insulin therapy would have significant occupational implications or weight loss would benefit other obesity-related comorbidities

It's really important to keep taking semaglutide for as long as your doctor says, because it's meant to be a long-term treatment

On the other hand, metoprolol succinates are taken once a day in an extended-release form

Budesonide-liposomes inclusion complex in thermosensitive gel alleviates DSS-induced ulcerative colitis in mice